Myocardial Infarction Risk After Discontinuation of Thienopyridine Therapy in the Randomized DAPT Study (Dual Antiplatelet Therapy)Clinical Perspective
Circulation - United States
doi 10.1161/circulationaha.116.024835
Full Text
Open PDFAbstract
Available in full text
Date
May 2, 2017
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)